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Cutaneous leukocytoclastic vasculitis (CLV) is an inflammatory vascular disorder rarely
reported to be associated with tuberculosis. The following report describes the case of a
young man with multifocal tuberculosis revealed by CLV. Diagnosis was confirmed by the
presence of tuberculoid granuloma with caseous necrosis on pleural and perianal biopsy,
and a rapid improvement in anti-tuberculous quadritherapy.
Although rarely seen, Mycobacterium tuberculosis should be considered as a potential
cause of CLV.
 2013 Asian-African Society for Mycobacteriology. Published by Elsevier Ltd. All rights
reserved.Introduction
Cutaneous leukocytoclastic vasculitis (CLV) is an inflamma-
tory vascular disorder due to deposition of immune com-
plexes in dermal vessels. It can have several causes,
including drugs, malignancy, collagen vascular disease, and
infection [1]. Among the infectious agents, bacteria are well
recognized as causes of CLV, but Mycobacterium tuberculosis
is rarely reported to be associated with CLV [2–4].
The following reports the case of a young man with multi-
focal tuberculosis whose initial presentation was that of a
lower limb leukocytoclastic vasculitis. This case seems to be
the first case reporting this association and discussing the
possible mechanisms.
Observation
A 19-year-old man with a history of perianal swelling for
1 month was admitted to the dermatological department
with a 1 week history of erythematous lesions of the lower-African Society for Myco
31.
o.fr (M. Meziane).limbs, fever, abdominal pain, and arthralgia of the knees,
ankles and wrists with weight loss. He had no other per-
sonal or familial history and had not taken any medications
recently. Upon physical examination, the finding was the
presence on both legs of several palpable purpuric lesions
that coalesced, resulting in vesicles (Fig. 1). Clinical exami-
nation also showed a 2 cm anal ulceration and a pleural left
effusion.
The blood workup revealed that the blood count, serum
creatinine, aspartate aminotransferase and alanine amino-
transferase were normal. The erythrocyte sedimentation rate
was 32 mm in the first hour, and the level of C-reactive pro-
tein was also elevated at 152 mg/l.
Serological markers for HIV, cytomegalovirus, Epstein-Barr
virus, hepatitis B and C, and syphilis were all negative. Rheu-
matoid factor, antinuclear antibody, anti-dsDNA antibody,
and anti-neutrophil cytoplasmic antibody (ANCA) were also
negative. Complement level was normal.
A chest X-ray showed a cavern in the right superior lobe
and a left pleurisy (Fig. 2). A sputum smear microscopybacteriology. Published by Elsevier Ltd. All rights reserved.
Fig. 2 – A chest X-ray, showing a cavern in the right superior
lobe and a left pleurisy.
Fig. 1 – Purpuric lesions of the dorsum of the foot.
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samples and skin testing with purified protein derivative
(PPD) was positive (induration of 14 mm).
A skin biopsy of the purpuric lesions was carried out. The
pathological skin analysis revealed leukocytoclastic vasculitis
(neutrophilic vasculitis of the small superficial vessels) and
immunofluorescence did not show the deposit of immuno-
globulin or complement. A pleural and perianal biopsy
showed tuberculoid granuloma with caseous necrosis. Poly-
merase chain reaction (PCR) determination of Mycobacterium
tuberculosis lesions was not done. A rectoscopy and colonos-
copy were normal. There were no signs of vasculitis present
in the internal organs.
The patient was diagnosed with CLV associated with mul-
tifocal tuberculosis (pleural, pulmonary and anal). He was
put under confinement to one’s bed and anti-tuberculosis
treatment was initiated with isoniazid, rifampin, pyrazina-
mide and ethambutol for 2 months followed by 7 months
of rifampicin and isoniazid, with a good response and
tolerance. The skin lesions showed gradual remission until
complete resolution after 2 weeks of treatment, the anal
lesion healed after 1 months and pleurisy after 4 weeks.
During the 6-month course of treatment, there was no
recurrence of purpura on the skin. A 2-year follow-up was
recommended.Discussion
CLV secondary to Mycobacterium tuberculosis is uncommon
with less than 20 cases reported currently [2–8].
Three main forms of the combination of tuberculosis and
vasculitis were described in literature: pulmonary tuberculo-
sis/Henoch–Scho¨nlein purpura; pulmonary tuberculosis/vas-
culitis secondary to rifampicin and pulmonary tuberculosis/
cutaneous leukocytoclastic vasculitis [8]. In this third category,
as in this case, CLVwas described in 12 patients, aged between
13 and 61 years old, with a slight male predominance [4–6,9].
In those 12 cases of CLV reported, vasculitis was associated
with pulmonary tuberculosis in 7 cases [4–6,9] andwith tuber-
culous lymphadenitis in4cases [2,4],while thesiteofMycobac-
teriumtuberculosis infectionwasnot found in1patient [3]. It is
believed that this observation is the first to date describing the
association between multifocal tuberculosis and CLV.
Clinically, CLV appears as palpable purpuric lesions on
both lower legs which can progressively spread to both thighs
or be accompanied by systemic symptoms as in this patient.
Purpura can be the first symptom of the disease or it can be
part of the overall clinical profile [6].
Histologically, the lesion is an angiocentric inflammatory
process associated with leukocytoclasia (neutrophil fragmen-
tation) and fibrinoid necrosis without the presence of Myco-
bacterium tuberculosis in the small vessel wall, which
differentiates it from cutaneous tuberculosis, in which micro-
organisms are seen in biopsy samples [6].
Even if cutaneous leukocytoclastic vasculitis is rare, it is
reported in the literature in young individuals with otherwise
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as was the profile of this patient. The exact pathogenesis of
CLV due to Mycobacterium tuberculosis remains unknown,
however, several mechanisms have been proposed: direct
invasion of vessel walls by tubercle bacilli; immunological
reaction involving the deposition of immune complexes;
intravascular release of mycobacteria followed by Arthus
reaction and delayed type hypersensitivity response; or Rif-
ampicin-dependent antibody and then immune complex for-
mation [8]. In this case, it is believed that an intravascular
release of mycobacteria from digestive, pulmonary tubercu-
lous pleural locations, which are highly vascularized,
participated to the direct invasion of vessel walls by mycobac-
terium tuberculosis.
Cutaneous leukocytoclastic vasculitis is treated by treating
the underlying disease; as in this case, a symptomatic treat-
ment of cutaneous lesions and anti-tuberculosis medication
are always sufficient with no recurrence after therapy [4]. In
hypersensitivity vasculitis caused by anti-tuberculosis ther-
apy (for example, rifampicin), discontinuation of the medica-
tion and its replacement improve skin lesions [6]. Severe skin
manifestations can be treated with a brief course of oral cor-
ticosteroids [1].
This report described a case of multifocal tuberculosis
associated with CLV confirmed by histology and therapy.
Although rarely seen, Mycobacterium tuberculosis should be
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